Higgins et al., 2023 - Google Patents
Principles of phosphoproteomics and applications in cancer researchHiggins et al., 2023
View HTML- Document ID
- 3708154607638727471
- Author
- Higgins L
- Gerdes H
- Cutillas P
- Publication year
- Publication venue
- Biochemical Journal
External Links
Snippet
Phosphorylation constitutes the most common and best-studied regulatory post-translational modification in biological systems and archetypal signalling pathways driven by protein and lipid kinases are disrupted in essentially all cancer types. Thus, the study of the …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hu et al. | Technical advances in proteomics: new developments in data-independent acquisition | |
Liu et al. | Mass spectrometric protein maps for biomarker discovery and clinical research | |
Ebhardt et al. | Applications of targeted proteomics in systems biology and translational medicine | |
Choudhary et al. | Decoding signalling networks by mass spectrometry-based proteomics | |
Gillet et al. | Mass spectrometry applied to bottom-up proteomics: entering the high-throughput era for hypothesis testing | |
Paša-Tolić et al. | Proteomic analyses using an accurate mass and time tag strategy | |
Maiolica et al. | Targeted proteome investigation via selected reaction monitoring mass spectrometry | |
Chen et al. | Amino acid-coded tagging approaches in quantitative proteomics | |
Plebani | Proteomics: the next revolution in laboratory medicine? | |
Röst et al. | Reproducible quantitative proteotype data matrices for systems biology | |
Gerritsen et al. | Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells | |
Skowronek et al. | Synchro-PASEF allows precursor-specific fragment ion extraction and interference removal in data-independent acquisition | |
Wirbel et al. | Phosphoproteomics-based profiling of kinase activities in cancer cells | |
Higgins et al. | Principles of phosphoproteomics and applications in cancer research | |
White et al. | Methods for the analysis of protein phosphorylation–mediated cellular signaling networks | |
Walhout et al. | Handbook of systems biology: concepts and insights | |
Lill et al. | Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade | |
Lin et al. | Mass spectrometry‐based targeted proteomics for analysis of protein mutations | |
Walsh et al. | Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies | |
Diamond et al. | HepatoProteomics: applying proteomic technologies to the study of liver function and disease | |
Yu et al. | One-stop analysis of DIA proteomics data using MSFragger-DIA and FragPipe computational platform | |
Gabriel et al. | Predicting fragment intensities and retention time of iTRAQ‐and TMTPro‐labeled peptides with Prosit‐TMT | |
Plymoth et al. | Proteomics beyond proteomics: toward clinical applications | |
Kinter et al. | Application of selected reaction monitoring to highly multiplexed targeted quantitative proteomics | |
Diederiks et al. | Development of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies |